Trial Evaluating the Benefit of Left Bundle Branch Area Stimulation Compared With Conventional Pacing in Post-TAVI Atrioventricular Atrioventricular Block

NCT ID: NCT07236489

Last Updated: 2025-12-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

266 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-11-25

Study Completion Date

2029-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Transcatheter aortic valve implantation (TAVI) has rapidly expanded over the past decade as a treatment for severe aortic valve stenosis, with over 14,000 procedures performed in France in 2021. A common complication following TAVI is traumatic atrioventricular block requiring pacemaker implantation, occurring in about 10% of patients. Conventional right ventricular pacing in these cases often leads to interventricular dyssynchrony, which can impair left ventricular ejection fraction and increase the risk of hospitalization, heart failure, and mortality.

Cardiac resynchronization therapy via biventricular pacing is sometimes proposed as a secondary intervention but involves additional surgery. A newer pacing technique-selective left bundle branch area pacing-has been developed to provide physiological ventricular activation by stimulating conduction pathways distal to the lesion, thereby avoiding dyssynchrony. Retrospective studies suggest clinical benefits, but no prospective randomized trial has yet evaluated its efficacy compared to standard pacing.

The objective of this study is to conduct the first randomized clinical trial comparing left bundle branch area pacing versus conventional right ventricular pacing in patients requiring pacemaker implantation due to atrioventricular block after TAVI.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Atrioventricular Block Pacemaker

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LBAP : Left Bundle Area Pacing

Pacemaker implantation using left bundle branch area stimulation

Group Type EXPERIMENTAL

Pacemaker implantation using left bundle branch area stimulation

Intervention Type PROCEDURE

Pacemaker implantation using left bundle branch area stimulation

RVP : Right Ventricular Pacing

Right ventricular pacemaker implantation

Group Type PLACEBO_COMPARATOR

Right ventricular pacemaker implantation

Intervention Type PROCEDURE

Right ventricular pacemaker implantation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pacemaker implantation using left bundle branch area stimulation

Pacemaker implantation using left bundle branch area stimulation

Intervention Type PROCEDURE

Right ventricular pacemaker implantation

Right ventricular pacemaker implantation

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who have undergone TAVI for severe aortic valve disease within the past 3 months
* Preserved left ventricular ejection fraction (LVEF ≥ 50%)
* Indications for pacemaker implantation according to guidelines, including :
* Third-degree atrioventricular (AV) block
* Second-degree AV block Mobitz type 2 or symptomatic Mobitz type 1
* Alternating left and right bundle branch block
* HV interval ≥ 70 ms during electrophysiological study
* Pre-existing right bundle branch block with worsening conduction disturbances post-TAVI
* Prolongation of QRS and PR intervals post-procedure justifying pacemaker implantation
* Signed informed consent
* Patient affiliated with the national health insurance system

Exclusion Criteria

* Left ventricular ejection fraction (LVEF) \< 50% before TAVI
* Contraindication to implantation of an endocardial pacemaker (vascular access issues, sepsis)
* Previously implanted pacemaker
* Patients under legal guardianship, curatorship, or judicial protection
* Participation in another interventional therapeutic clinical trial
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nantes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Brest University Hospital

Brest, Finistère, France

Site Status NOT_YET_RECRUITING

Rennes University Hospital

Rennes, Ille-et-Vilaine, France

Site Status NOT_YET_RECRUITING

Tours University Hospital

Tours, Indre-et-Loire, France

Site Status NOT_YET_RECRUITING

Nantes University Hospital

Nantes, Loire-Atlantique, France

Site Status RECRUITING

Clermont Ferrand University Hospital

Clermont-Ferrand, Puy-de-Dôme, France

Site Status NOT_YET_RECRUITING

Rouen University Hospital

Rouen, Seine-Maritime, France

Site Status NOT_YET_RECRUITING

Poitiers University Hospital

Poitiers, Vienne, France

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Research and Innovation Departement of Nantes UH

Role: CONTACT

+33253482810

Damien MINOIS, M.D

Role: CONTACT

+33244768742

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jacques MANSOURATI, UH Practitioner

Role: primary

+33298347405

Nathalie BEHAR, M.D

Role: primary

+33299282517

Arnaud BISSON, M.D

Role: primary

+33247474787

Damien MINOIS, M.D

Role: primary

+33244768742

Romain ESCHALIER, UH Practitioner

Role: primary

+33473751410

Frédéric ANSELME, UH Practitioner

Role: primary

+33235521638

Rodrigue GARCIA, UH Practitioner

Role: primary

+33603847546

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RC24_0610

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Short Atrioventricular Delay Pacing
NCT01233661 WITHDRAWN NA